Reutzel-Edens SM - Search Results

1

Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabine.

Bender DM, Bao J, Dantzig AH, Diseroad WD, Law KL, Magnus NA, Peterson JA, Perkins EJ, Pu YJ, Reutzel-Edens SM, Remick DM, Starling JJ, Stephenson GA, Vaid RK, Zhang D, McCarthy JR. Bender DM, et al. J Med Chem. 2009 Nov 26;52(22):6958-61. doi: 10.1021/jm901181h. J Med Chem. 2009. PMID: 19860433

2

Characterization of the solid state: quantitative issues.

Stephenson GA, Forbes RA, Reutzel-Edens SM. Stephenson GA, et al. Adv Drug Deliv Rev. 2001 May 16;48(1):67-90. doi: 10.1016/s0169-409x(01)00099-0. Adv Drug Deliv Rev. 2001. PMID: 11325477 Review.

3

Assessment of the amorphous "solubility" of a group of diverse drugs using new experimental and theoretical approaches.

Almeida e Sousa L, Reutzel-Edens SM, Stephenson GA, Taylor LS. Almeida e Sousa L, et al. Mol Pharm. 2015 Feb 2;12(2):484-95. doi: 10.1021/mp500571m. Epub 2014 Dec 29. Mol Pharm. 2015. PMID: 25495614

4

Crystal forms of LY334370 HCl: isolation, solid-state characterization, and physicochemical properties.

Reutzel-Edens SM, Kleemann RL, Lewellen PL, Borghese AL, Antoine LJ. Reutzel-Edens SM, et al. J Pharm Sci. 2003 Jun;92(6):1196-205. doi: 10.1002/jps.10373. J Pharm Sci. 2003. PMID: 12761809

5

The potential of computed crystal energy landscapes to aid solid-form development.

Price SL, Reutzel-Edens SM. Price SL, et al. Drug Discov Today. 2016 Jun;21(6):912-23. doi: 10.1016/j.drudis.2016.01.014. Epub 2016 Feb 2. Drug Discov Today. 2016. PMID: 26851154 Review.

6

Achieving polymorph selectivity in the crystallization of pharmaceutical solids: basic considerations and recent advances.

Reutzel-Edens SM. Reutzel-Edens SM. Curr Opin Drug Discov Devel. 2006 Nov;9(6):806-15. Curr Opin Drug Discov Devel. 2006. PMID: 17117688 Review.

7

Insight into Amorphous Solid Dispersion Performance by Coupled Dissolution and Membrane Mass Transfer Measurements.

Hate SS, Reutzel-Edens SM, Taylor LS. Hate SS, et al. Mol Pharm. 2019 Jan 7;16(1):448-461. doi: 10.1021/acs.molpharmaceut.8b01117. Epub 2018 Dec 18. Mol Pharm. 2019. PMID: 30521350

8

Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.

Newman A, Reutzel-Edens SM, Zografi G. Newman A, et al. J Pharm Sci. 2018 Jan;107(1):5-17. doi: 10.1016/j.xphs.2017.09.024. Epub 2017 Oct 5. J Pharm Sci. 2018. PMID: 28989014

9

Absorptive Dissolution Testing: An Improved Approach to Study the Impact of Residual Crystallinity on the Performance of Amorphous Formulations.

Hate SS, Reutzel-Edens SM, Taylor LS. Hate SS, et al. Among authors: reutzel edens sm. J Pharm Sci. 2020 Mar;109(3):1312-1323. doi: 10.1016/j.xphs.2019.11.016. Epub 2019 Nov 22. J Pharm Sci. 2020. PMID: 31765652

10

Symmetry in the making.

Reutzel-Edens SM. Reutzel-Edens SM. Nat Chem. 2020 Oct;12(10):887-888. doi: 10.1038/s41557-020-0547-8. Nat Chem. 2020. PMID: 32968228 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters